UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?

Leukemia, 2019-04, Vol.33 (4), p.1023-1029

2019

Volltextzugriff (PDF)

Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis

American journal of hematology, 2022-02, Vol.97 (2), p.203-208

2022

Volltextzugriff (PDF)

A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome

American journal of hematology, 2018-06, Vol.93 (6), p.803-809

2018

Volltextzugriff (PDF)

Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis

Leukemia, 2022-02, Vol.36 (2), p.573-576

2022

Volltextzugriff (PDF)

Pulmonary manifestations of Erdheim–Chester disease: clinical characteristics, outcomes and comparison with Langerhans cell histiocytosis

British journal of haematology, 2021-09, Vol.194 (6), p.1024-1033

2021

Volltextzugriff (PDF)

Patterns and organ treatment response of Erdheim-Chester disease with cardiac involvement

Heart (British Cardiac Society), 2024-05, Vol.110 (13), p.899

2024

Volltextzugriff (PDF)

A highly heterogeneous mutational pattern in POEMS syndrome

Leukemia, 2021-04, Vol.35 (4), p.1100-1107

2021

Volltextzugriff (PDF)

Clinical characteristics, radiological features and outcomes in pulmonary involvement of cryoglobulinemia

Orphanet journal of rare diseases, 2024-05, Vol.19 (1), p.185-185, Article 185

2024

Volltextzugriff (PDF)

Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study

American journal of hematology, 2020-09, Vol.95 (9), p.E235-E238

2020

Volltextzugriff (PDF)

Treatment and outcomes of POEMS syndrome: changes in the past 20 years

Blood cancer journal (New York), 2021-08, Vol.11 (8), p.145-145, Article 145

2021

Volltextzugriff (PDF)

Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma

PloS one, 2020-02, Vol.15 (2), p.e0229089-e0229089

2020

Volltextzugriff (PDF)

Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial‐mesenchymal transition in salivary adenoid cystic carcinoma

Cell proliferation, 2019-05, Vol.52 (3), p.e12600-n/a

2019

Volltextzugriff (PDF)

Rituximab-containing therapy for cold agglutinin disease: a retrospective study of 16 patients

Scientific reports, 2020-07, Vol.10 (1), p.12694, Article 12694

2020

Volltextzugriff (PDF)

EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells

Journal of cellular and molecular medicine, 2019-10, Vol.23 (10), p.6942-6954

2019

Volltextzugriff (PDF)

CXCL12/CXCR4 facilitates perineural invasion via induction of the Twist/S100A4 axis in salivary adenoid cystic carcinoma

Journal of cellular and molecular medicine, 2021-08, Vol.25 (16), p.7901-7912

2021

Volltextzugriff (PDF)

Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement

BMC cancer, 2020-09, Vol.20 (1), p.911-911, Article 911

2020

Volltextzugriff (PDF)

Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients: a single-center study of 45 patients

Annals of hematology, 2020-08, Vol.99 (8), p.1735-1740

2020

Volltextzugriff (PDF)

Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease

Orphanet journal of rare diseases, 2019-01, Vol.14 (1), p.11-11, Article 11

2019

Volltextzugriff (PDF)

Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial

Circulation (New York, N.Y.), 2022-01, Vol.145 (1), p.8-17

2022

Volltextzugriff (PDF)

Cytokeratin-14 contributes to collective invasion of salivary adenoid cystic carcinoma

PloS one, 2017-02, Vol.12 (2), p.e0171341-e0171341

2017

Volltextzugriff (PDF)

Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease

Blood, 2019-04, Vol.133 (16), p.1720-1728

2019

Volltextzugriff (PDF)

Pulmonary hypertension in POEMS syndrome

Haematologica (Roma), 2013-03, Vol.98 (3), p.393-398

2013

Volltextzugriff (PDF)

Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome

European journal of haematology, 2015-10, Vol.95 (4), p.325-330

2015

Volltextzugriff (PDF)

Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia

Annals of hematology, 2024-09, Vol.103 (9), p.3667-3675

2024

Volltextzugriff (PDF)

At least partial hematological response after first cycle of treatment predicts organ response and long-term survival for patients with AL amyloidosis receiving bortezomib-based treatment

Annals of hematology, 2017-12, Vol.96 (12), p.2089-2094

2017

Volltextzugriff (PDF)

1 – 25 von 1.059

Suche als RSS-Feed

Aktive Filter

ThemaMale

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(825)
Mit Volltextzugriff
(841)

Publikationsform

Artikel
(1.059)

Sprache

Englisch
(877)
Chinesisch
(185)

Erscheinungsjahr

n.n

Thema

13 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?

Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis

A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome

Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis

Pulmonary manifestations of Erdheim–Chester disease: clinical characteristics, outcomes and comparison with Langerhans cell histiocytosis

Patterns and organ treatment response of Erdheim-Chester disease with cardiac involvement

A highly heterogeneous mutational pattern in POEMS syndrome

Clinical characteristics, radiological features and outcomes in pulmonary involvement of cryoglobulinemia

Methotrexate and cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis: A single arm, single center, prospective phase 2 study

Treatment and outcomes of POEMS syndrome: changes in the past 20 years

Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma

Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial‐mesenchymal transition in salivary adenoid cystic carcinoma

Rituximab-containing therapy for cold agglutinin disease: a retrospective study of 16 patients

EZH2 promotes invasion and tumour glycolysis by regulating STAT3 and FoxO1 signalling in human OSCC cells

CXCL12/CXCR4 facilitates perineural invasion via induction of the Twist/S100A4 axis in salivary adenoid cystic carcinoma

Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement

Clinical characteristics and treatment outcome of type I cryoglobulinemia in Chinese patients: a single-center study of 45 patients

Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease

Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial

Cytokeratin-14 contributes to collective invasion of salivary adenoid cystic carcinoma

Phase 2 study using oral thalidomide-cyclophosphamide-prednisone for idiopathic multicentric Castleman disease

Pulmonary hypertension in POEMS syndrome

Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome

Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia

At least partial hematological response after first cycle of treatment predicts organ response and long-term survival for patients with AL amyloidosis receiving bortezomib-based treatment

Aktive Filter

Suchergebnisse filtern